Skip to content
value.today
Vaxxinity, Inc. logo

Vaxxinity, Inc.

🇺🇸 Dallas, Texas, USABiotechnologyFounded 2021
Total raised
$27 M
1 round on record
Latest round
$27 M
Mar 2021
First round on record
Mar 2021
Today
Went public
See the company page

Vaxxinity, Inc. is listed today as Vaxxinity, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Vaxxinity, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2021$27 MNo. 1$10 to $50 million

Vaxxinity, Inc.: Raise no. 1, Mar 2021

Investors in this round

9 investors had bought by the notice of Mar 31, 2021: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$27 M of $100 M offered; $73 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mei Mei Hu · Executive Officer, Director
  • Dakin Sloss · Director
  • James Chui · Director
  • Louis Reese · Director
  • Peter Diamandis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mei Mei Hu, Chief Executive Officer/President. Newest notice filed Mar 31, 2021. Read the notice at the SEC.

equitySEC
Mar 2021$1.4 BIssued in a merger or acquisition$1 billion or more

Vaxxinity, Inc.: Private sale, Mar 2021

Investors in this round

81 investors had bought by the notice of Mar 17, 2021: 81 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1.4 B (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mei Mei Hu · Executive Officer, Director
  • Dakin Sloss · Director
  • James Chui · Director
  • Louis Reese · Director
  • Peter Diamandis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mei Mei Hu, Chief Executive Officer/President. Newest notice filed Mar 17, 2021. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vaxxinity, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2021).

    SEC Form D · Mar 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2021

Products and services#

No products or services of Vaxxinity, Inc. are on record.

Investors#

No investor of Vaxxinity, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vaxxinity, Inc.
NameRoleNamed in
Mei Mei HuExecutive officerMar 2021
Dakin SlossDirectorMar 2021
James ChuiDirectorMar 2021
Louis ReeseDirectorMar 2021
Mei Mei HuDirectorMar 2021
Peter DiamandisDirectorMar 2021

Went public since 2021. Its SEC number is that of a company listed on a stock exchange.